February 25, 2019 — The Wall Street Journal headline reads: GE to Sell Its Biotech Business for $21 Billion. I now know for certain that we're in a topsy-turvy world. Back in 1980 it was lawyers for the General Electric company that persuaded the U.S. Supreme Court to affirm, in the legendary decision of Diamond v. [...]
Supreme Court, snowed by ACLU smear campaign, resurrects archaic requirement of “invention” as a test of patent eligibility.
In their decision June 13, 2013, in Association for Molecular Pathology v. Myriad Genetics, the Supreme Court seems to have been snowed by an anti-patent publicity campaign engineered by a brilliant but diabolical law professor and gullible lawyers at the venerable ACLU. The opinion of the Court resurrects an archaic requirement of "invention" that was [...]
Two hearings have been scheduled by the US PTO on the effect of patents for Genetic Testing, to support the study that the PTO is mandated by the Leahy-Smith America Invents Act ("AIA") to generate for Congress. The first of the hearings is today. It will be broadcast via the Web. The second of the [...]